Advisor Group’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $3K | Buy |
+2,000
| New | +$3K | ﹤0.01% | 4887 |
|
|
2019
Q2 | – | Sell |
-25
| Closed | – | – | 5502 |
|
|
2019
Q1 | $0 | Sell |
25
-75
| -75% | – | ﹤0.01% | 5408 |
|
|
2018
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 5336 |
|
|
2018
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 5313 |
|
|
2018
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 5127 |
|
|
2018
Q1 | $1K | Sell |
100
-75
| -43% | -$750 | ﹤0.01% | 4885 |
|
|
2017
Q4 | $2K | Hold |
175
| – | – | ﹤0.01% | 4747 |
|
|
2017
Q3 | $2K | Hold |
175
| – | – | ﹤0.01% | 4602 |
|
|
2017
Q2 | $2K | Hold |
175
| – | – | ﹤0.01% | 4557 |
|
|
2017
Q1 | $2K | Hold |
175
| – | – | ﹤0.01% | 4452 |
|
|
2016
Q4 | $2K | Buy |
175
+75
| +75% | +$857 | ﹤0.01% | 4282 |
|
|
2016
Q3 | $2K | Hold |
100
| – | – | ﹤0.01% | 4226 |
|
|
2016
Q2 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 4316 |
|